| 000 | 00799nam a22002897a 4500 | ||
|---|---|---|---|
| 001 | D0001B000107 | ||
| 003 | DOH | ||
| 005 | 20201216144021.0 | ||
| 008 | 201216b ||||| |||| 00| 0 eng d | ||
| 040 | _erda | ||
| 245 | 0 | 0 |
_aGuide to drug financing mechanisms / _cJérôme Dumoulin [and two others] |
| 260 |
_aGeneva : _bWHO, _c1998. |
||
| 300 | _a55 p. | ||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 650 | 2 | _aEconomics, Pharmaceutical | |
| 650 | 2 | _aDrug Costs | |
| 650 | 2 | _aDrug Utilization | |
| 650 | 2 | _aPharmaceutical Preparations | |
| 650 | 2 | _aPrescription Drugs | |
| 700 | 1 | _aDumoulin, Jérôme | |
| 700 | 1 | _aKaddar, Miloud | |
| 700 | 1 | _aVelásquez, Germán | |
| 710 | 2 | _aWorld Health Organization | |
| 942 |
_2nlm _cBK |
||
| 999 |
_c2089 _d2089 |
||